Immune Pharmaceuticals, Inc.
(NASDAQ : IMNP)

( )
IMNP After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-10.75%19.6814.1%$423.46m
SAGESAGE Therapeutics, Inc.
-4.02%158.0310.9%$226.59m
SHPGShire PLC Sponsored ADR
-0.08%147.200.4%$159.41m
PRGOPerrigo Co. Plc
-2.27%84.076.6%$82.08m
MNKMallinckrodt Plc
-3.10%23.1218.5%$78.88m
GWPHGW Pharmaceuticals PLC Sponsored ADR
5.52%130.827.6%$60.16m
JAZZJazz Pharmaceuticals Plc
-3.65%135.502.2%$53.33m
UTHRUnited Therapeutics Corporation
-0.37%135.7814.5%$51.60m
ICPTIntercept Pharmaceuticals, Inc.
-4.03%61.6122.0%$38.01m
RVNCRevance Therapeutics, Inc.
-5.72%32.1512.2%$36.25m
MDCOMedicines Company
-1.45%27.2522.1%$35.42m
ENDPEndo International Plc
0.00%7.818.9%$32.98m
CTLTCatalent Inc
0.08%40.052.6%$31.80m
ADMSAdamas Pharmaceuticals, Inc.
-3.81%32.0816.9%$31.56m
PTLAPortola Pharmaceuticals, Inc.
-3.73%47.557.8%$30.99m

Company Profile

Immune Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It engages in the acquisition, development, and commercialization of prescription drug products. It offers mAbs nanotherapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. The company was founded by Daniel Gedeon Teper on August 25, 2013 and is headquartered in Englewood Cliffs, NJ.